Bunkerhill Health receives FDA clearance for an AI model that detects mitral annular calcification (MAC) on routine, non-gated CT scans.
Key Details
- 1Bunkerhill Health’s AI model (Bunkerhill MAC) is FDA-cleared to detect and evaluate MAC.
- 2The tool works on routine, non-gated CT scans, expanding accessibility for cardiovascular risk detection.
- 3This is the first FDA-approved AI specifically for MAC identification.
- 4Development included data from over 25 academic medical centers, including Stanford University.
- 5The algorithm is integrated into Carebricks, Bunkerhill Health’s generative AI platform.
Why It Matters
This clearance introduces a new, scalable AI solution to consistently identify a cardiovascular risk marker that can be missed in routine practice, potentially improving patient care and research. Automating MAC detection could significantly impact cardiovascular and structural heart disease assessments in radiology workflows.
Source
Cardiovascular Business
Related News
•Cardiovascular Business
Best Practices for Integrating AI Into Cardiac Imaging Workflows
Successful AI integration in cardiac imaging requires more than just software installation, emphasizing the need for clinician leadership and multidisciplinary coordination.
•Cardiovascular Business
AI Finds Hidden Aortic Stenosis in Routine Chest CTs
AI algorithms can identify undiagnosed aortic stenosis on routine chest CT scans, potentially improving early detection and patient care.
•Radiology Business
Medicare Grants Add-On Payment for Aidoc's AI CT Body Triage Tool
Medicare has approved new inpatient add-on payments for Aidoc's AI-powered CT Body Triage tool, supporting hospitals' adoption of this technology.